Yes, I agree with you about best possible source of outcome and Bisantrene definitely looks very promising there. I only raised the question because when I ran this opportunity by a few friends who are in the medical field (i.e. nuclear medicine and nursing etc.) and one of the first question was its cost and whether it would actually be affordable to use compared to current offerings.
Now I understand that RAC isn't really about the commercial aspects of it but would still be nice to get somewhat of an idea.
General Comments / Chat, page-924
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.100(6.45%) |
Mkt cap ! $279.5M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.61 | $374.5K | 223.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5794 | $1.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1975 | 3 |
View Market Depth
| Last trade - 11.02am 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.69 |
Change
0.100 ( 9.92 %) |
||||
| Open | High | Low | Volume | ||
| $1.64 | $1.73 | $1.63 | 16053 | ||
| Last updated 11.21am 14/05/2024 ? | |||||
| RAC (ASX) Chart |